Ming Xian - 20 Jun 2024 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
20 Jun 2024
Net transactions value
$0
Form type
4
Filing time
24 Jun 2024, 17:47:31 UTC
Previous filing
09 Nov 2023
Next filing
26 Jun 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MED Restricted Stock Units (cash settled) Award $0 +10,149 +211% $0.000000 14,962 20 Jun 2024 Common Stock 10,149 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.